![](http://medicine.buffalo.edu/content/shared/smbs/news/2020/01/neurovascular-diagnostics-funding-10676/jcr%3acontent/par/image.img.447.260.jpg/1576600923153.jpg)
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).
More about this challenge at: Original Source